PMA device
Syncardia Companion 2 Driver System
Syncardia Systems, LLC · Artificial Heart (LOZ, Class III) · First FDA decision Aug 20, 2012, newest Aug 20, 2012Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Companion 2 Driver"
MAUDE reports
648
Brand "Companion 2 Driver", since 2015
PubMed studies
0
Mentioning "Companion 2 Driver"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Syncardia Companion 2 Driver System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- SYNCARDIA COMPANION 2 DRIVER SYSTEMPMA supplement
P030011-S016 · Decided Aug 20, 2012 · 60 days after receipt · Normal 180 Day Track No User Fee
Device type: Artificial heart (LOZ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Artificial Hearts and related devices, including Ventricular Assist Devices for Bridge-to-Transplant and Destination TherapyNational analysisReview closedCAG-00453NUpdated Nov 19, 2026
- Artificial HeartsNational analysisReview closedCAG-00322NUpdated Sep 16, 2026
- Artificial Hearts and Related Devices - RETIREDNational determinationOn the books20.9Updated Jun 5, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Companion 2 Driver", any status and sponsor, newest update first.
- SynCardia Companion 2 Driver System Post Approval Study Protocol With INTERMACS™-Based Data CollectionStatus unknown
SynCardia Systems. LLCNot on our public-company list
NCT01919320 · 500 participants (planned) · Start Dec 2013 · Primary completion Dec 2022
Device: C2 Driver System TAH-t Patients; CSS Console TAH-t Patients · For: Bi-ventricular Failure
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Companion 2 Driver", and for the whole product code for context.
This brand
648 reports: 620 malfunction, 25 injury, 3 death
Whole product code LOZ
3,209 reports: 2,545 malfunction, 279 injury, 384 death
Newest reports for this brand
- Syncardia Companion 2 Driver SystemMalfunction
3003761017-2026-00205 · Received Oct 28, 2026 · Event dated Oct 12, 2026
Device type: Artificial Heart (LOZ)
Device problem as coded: Loose or Intermittent Connection; Noise, Audible
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SynCardia Companion 2 DriverMalfunction
3003761017-2026-00114 · Received Oct 21, 2026 · Event dated Feb 10, 2026
Device type: Artificial Heart (LOZ)
Device problem as coded: Audible Prompt/Feedback Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SynCardia Companion 2 DriverMalfunction
3003761017-2026-00146 · Received Oct 21, 2026 · Event dated Dec 13, 2023
Device type: Artificial Heart (LOZ)
Device problem as coded: Battery Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0126-2024 · Started Aug 1, 2023 · Posted by FDA Oct 20, 2023
Reason given: Artificial hearts contain a epoxy resin that has not been reviewed by the FDA for safety and efficacy.
Cause as FDA categorized it: Other · Device type: Artificial Heart (LOZ)
- SynCardia Total Artificial Heart System (70CC): 500101-001 SynCardia Total Artificial Heart System (50CC): 570500-000Open, Classified
Z-1022-2023 · Started Nov 2, 2022 · Posted by FDA Jan 27, 2023
Reason given: Due to tears reported tears in the cannula due to wear and tear stress.
Cause as FDA categorized it: Device Design · Device type: Artificial Heart (LOZ)
Z-0659-2017 · Started Oct 21, 2016
Reason given: The Main Printed Circuit Board Assembly (PCBA) of the affected Freedom Drivers may fail and cause the Freedom Driver to stop functioning without visual or audible alarms, resulting in the loss of life-sustaining function.
Cause as FDA categorized it: Process control · Device type: Artificial Heart (LOZ)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Companion 2 Driver"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LOZ.
- SynCardia temporary Total Artificial Heart (TAH-t) SystemSyncardia Systems, LLC · PMA 2023
- Total Artificial HeartSyncardia Systems, LLC · PMA 2025
- Cardiowest Temporary Total Artifical Heart (Tah-T) SystemSyncardia Systems, LLC · PMA 2008
- Syncardia Temporary Cardiowest Total Artificial Heart (Tah-T)Syncardia Systems, LLC · PMA 2005
- Syncardia Temporary Cardio West Total Artificial Heart (Tah-T)Syncardia Systems, LLC · PMA 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.